View more in
Cancer

Dr. Raghav on Adjusting Dosing With Regorafenib in CRC

onclive.com
 2021-05-11

Kanwal Raghav, MBBS, MD, discusses adjusting dosing with regorafenib in patients with colorectal cancer. Kanwal Raghav, MBBS, MD, an associate professor in the Department of Gastrointestinal Medical Oncology, of the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, discusses adjusting dosing with regorafenib (Stivarga) in patients with colorectal cancer (CRC).

www.onclive.com

Comments / 0

Comments / 0